Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Year-over-year earnings per share growth rate
Latest
-147.25%
↓ 451% vs avg
Percentile
P10
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
-26.70%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -147.25% |
| Q3 2025 | 700.00% |
| Q2 2025 | -83.33% |
| Q1 2025 | 115.79% |
| Q4 2024 | -425.34% |
| Q3 2024 | 41.40% |
| Q2 2024 | -54.36% |
| Q1 2024 | 113.31% |
| Q4 2023 | -1410.21% |
| Q3 2023 | -35.13% |
| Q2 2023 | 4.17% |
| Q1 2023 | 239.64% |
| Q4 2022 | -0.55% |
| Q3 2022 | -172.26% |
| Q2 2022 | -5.49% |
| Q1 2022 | 112.32% |
| Q4 2021 | 18.75% |
| Q3 2021 | -25.00% |
| Q2 2021 | 18.99% |
| Q1 2021 | 7.06% |
| Q4 2020 | -16.44% |
| Q3 2020 | 23.96% |
| Q2 2020 | -242.86% |
| Q1 2020 | 75.22% |
| Q4 2019 | -6.60% |
| Q3 2019 | 7.83% |
| Q2 2019 | 8.73% |
| Q1 2019 | -38.46% |
| Q4 2018 | -42.19% |
| Q3 2018 | -18.52% |
| Q2 2018 | 3.57% |
| Q1 2018 | 55.56% |
| Q4 2017 | 5.97% |
| Q3 2017 | 11.84% |
| Q2 2017 | 66.74% |
| Q1 2017 | 2.35% |
| Q4 2016 | 22.52% |
| Q3 2016 | 4.58% |
| Q2 2016 | -34.39% |
| Q1 2016 | 30.01% |